CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
  (PFHO)
Other Ticker:  
 
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for in the second quarter 2024?
achieved a return on average equity (ROE) of 7.14 % in its second quarter 2024, which is below 's average return on equity, which stands at 12.08%.

ROE has advanced compared to 6.32% in the first quarter 2024, due to net income growth.

Within the Healthcare Facilities industry 12 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2024 from 0 to 1301.

What is ROE?



Return On Equity (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Equity Change -2.02 % -2.79 % -7.12 % -7.13 % -
Y / Y Net Income Change 64.41 % - -6.71 % 41.68 % -30.46 %
Net Income (TTM) in Millions 1 1 0 0 0
Return On Equity (TTM) 7.14 % 6.32 % 4.35 % 4.39 % 3.85 %
PFHO's Total Ranking # 1301 # 0 # 1916 # 1952 #
Equity (TTM) in Millions 11 11 11 10 11
Seq. Equity Change 1.96 % 4.55 % 1.73 % -9.65 % 1.16 %
Seq. Net Income Change 9.2 % 10.21 % 1.53 % 34.57 % -

Back to PFHO Management Effectiveness >> PFHO's 5 Years Annual ROE >> Compare PFHO ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 13
Sector # 111
Overall # 1301

Return On Equity Statistics
High Average Low
36.99 %
12.08 %
3.85 %
(Sep. 30, 2015)   (Mar 31 2023)





PFHO Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions 11 11 10 9 8
Y / Y Equity Change 4.55 % 10.12 % 5.92 % 14.82 % 20.23 %
Net Income in Millions 0 1 1 1 1
Y / Y Net Income Change -50.46 % 81.05 % -54.13 % -11.89 % 41 %
Return On Equity 4.36 % 9.19 % 5.59 % 12.91 % 16.83 %

Back to PFHO Management Effectiveness >> PFHO's 5 Years Annual ROE >> Compare PFHO ROE to its Competitors




Annual Roe Comment
In 2022 ROE decreased compared to the previous year to 4.36 %, due to deterioration of net income.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PFHO's' Return on Equity at Yahoo Finance
PFHO's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for PFHO's Competitors
Return On Equity for 's Suppliers
Roe for PFHO's Customers




Companies with similar Return On Equity at Jun 30 2024, within Healthcare Sector ROE
West Pharmaceutical Services Inc   19.08 %
United Therapeutics Corporation  18.82 %
Hologic Inc  17.61 %
Alpha Pro Tech Ltd   17.35 %
Ufp Technologies Inc   17.03 %
Tactile Systems Technology Inc   16.92 %
Patterson Companies Inc   16.88 %
Regeneron Pharmaceuticals Inc   16.30 %
Kiora Pharmaceuticals Inc   15.57 %
Intuitive Surgical Inc   15.38 %
Abbott Laboratories  15.08 %
American Shared Hospital Services  15.04 %
Neurocrine Biosciences Inc   14.86 %
Option Care Health Inc   14.82 %
Ensign Group Inc  14.55 %
Zynex inc   14.15 %
Quest Diagnostics Inc  13.73 %
Krystal Biotech Inc   13.36 %
The Pennant Group Inc   12.95 %
Vaso Corporation  12.61 %
Charles River Laboratories International inc   12.48 %
Electromed Inc   12.44 %
Haemonetics Corporation  12.41 %
Lemaitre Vascular Inc   12.41 %
Progyny Inc   11.97 %
Align Technology inc   11.96 %
Conmed Corporation  11.71 %
Jazz Pharmaceuticals Plc  10.76 %
Lifevantage Corp  10.74 %
Nature s Sunshine Products inc   10.49 %

Date modified: 2024-09-13T08:20:38+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com